Head-to-head · Value Score
CoreAge Rx vs Queen RX
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Queen RX a 80. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameQueen RX
#61 · Grade B · Good Value
Est. first month
From $100/mo (quarterly plan, compounded)
Save ~93% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 80 — an est. $99/mo first month, with no teaser step-up baked in. Queen RX isn't out of it: Someone who would rather buy a quarter outright than be enrolled in a recurring plan.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Queen RX |
|---|---|---|
| Value Score | 93 (A+) | 80 (B) |
| Est. first month | $99/mo | From $100/mo (quarterly plan, compounded) |
| Save vs brand-name | ~89% | ~93% |
| Semaglutide | $99/mo | From $100/mo (quarterly plan, compounded) |
| Tirzepatide | $149/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 45 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Queen RX
Queen RX sells compounded GLP-1 treatment as a flat $299 quarterly purchase with no subscription or membership fee, covering semaglutide, tirzepatide and liraglutide across 45 states.
Why it's a deal
- A one-time quarterly purchase at $299 with no subscription and no membership fee, which is unusual in a category built on recurring billing
- A full refund if the application is not approved, so the money is not at risk before a prescriber has looked
- Three molecules on one account - semaglutide, tirzepatide and liraglutide - where most sellers carry two
- Names the five states it does not serve rather than leaving coverage vague
The fine print
- The price is quarterly, so the entry cost is $299 in one payment rather than about $100 a month
- Not available in Kansas, Louisiana, Mississippi, New Mexico or West Virginia
- No LegitScript or PCAB accreditation displayed, and no pharmacy partner named
- No legal entity name or business address is published anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Queen RX.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.